Objective The optimal prognostic model for community-acquired pneumonia (CAP) remains unclear. In this study, we sought to identify independent predictors of 30-day mortality in patients with CAP and to determine whether adding specific prognostic factors to each of the two clinical prediction scores could improve the prognostic yield. Methods This retrospective study involved 797 CAP patients who had been hospitalized at a tertiary referral center. The patients were categorized into two groups: those who survived and those who had died on or before 30 days after admission. Select clinical parameters were then compared between the two groups. Results During the 30-day period, there were 72 deaths (9%). We constructed two models for a multivariate analysis: one was based on a high CURB-65 score (3-5) and the other on a high pneumonia severity index (PSI) class (V). In both models, a high CURB-65 score or a high PSI class, along with the presence of dyspnea, high Eastern Cooperative Oncology Group (ECOG) performance status (3-4), and a low serum albumin level, were independent predictors of 30-day mortality. In both the CURB-65-based and PSI-based models, the addition of dyspnea, high ECOG performance status, and hypoalbuminemia (<3 g/dL) enhanced the prognostic assessment, and subsequently, the c-statistics calculated with the use of three-or four-predictor combinations exceeded 0.8. Conclusion In addition to the CURB-65 or PSI, the clinical factors of dyspnea, the ECOG performance status, and serum albumin level may be independent predictors of 30-day mortality in CAP patients. When combined with the CURB-65 or PSI, these parameters provide additional evidence for predicting poor prognoses.
Introduction
In 2010, pneumonia was the ninth most common cause of death in the United States (1) , and lower respiratory tract infections, including pneumonia, were the fourth most common cause of death globally according to the 2010 Global Burden of Disease Study (2) . Although the incidence of community-acquired pneumonia (CAP) varies depending on the population studied, a recent European study has reported an overall annual incidence of 1.1-1.7 per 1,000 persons (3) . In hospitalized patients, CAP is associated with a mortality rate of 5-15% (4), thus making CAP the leading cause of death due to infectious disease (5) .
These epidemiological findings ensure that the identification of specific prognostic factors remains a key objective for clinicians involved in the care of patients with CAP. Optimal management of CAP requires the prompt recognition of those patients who are more seriously ill (6) . In this context, two predictive assessment tools were introduced infor death, however, it underestimates the severity of illness in young patients who are free of comorbid conditions. In contrast, the CURB-65 criteria may be ideal for identifying patients at high risk for death and with severe illness (6) . Although these two scoring systems have been studied extensively, they are still not sufficient for predicting the outcomes of patients with CAP.
If certain other prognostic factors were combined with each of these two models, then our ability to determine the prognosis would likely be enhanced. To date, several groups have focused on combining the levels of certain biomarkers of inflammation, including blood levels of procalcitonin and C-reactive protein (CRP), with the CURB-65 score or the PSI (9-11); however, the ideal combination of prognostic factors has still not been established. The aim of our study was to identify independent predictors of 30-day mortality in CAP patients and to investigate whether adding certain clinical factors to the results of the CURB-65 or PSI assessment could improve the prognostic yield.
Materials and Methods

Study design
Using the CAP patient registry, we identified consecutive CAP patients who had been treated between January 2011 and December 2013 at the Respiratory Department of Kyungpook National University Hospital (KNUH), a tertiary referral center, in Daegu, South Korea. On admission, all patients were prospectively enrolled in this study, and their baseline characteristics were recorded, although not all patients underwent the same laboratory tests. Pneumonia was diagnosed if a patient met the following criteria: (a) radiographic evidence of a new infiltrate and (b) two or more compatible symptoms or signs (a cough, sputum, dyspnea, a fever, pleuritic chest pain, and/or other findings consistent with pneumonia). Exclusion criteria included: (a) hospitalacquired pneumonia or healthcare-associated pneumonia (12), (b) active thoracic malignancy, (c) immunosuppression or steroid use (equivalent to prednisone >15 mg/day for >14 days), and (d) patients in whom antibiotic treatment had been initiated previously in other clinics or hospitals. The primary endpoint was 30-day mortality, and various clinical parameters were compared between the two groups. This study was approved by the Institutional Review Board of KNUH, which waived the requirement for written informed consent because of the retrospective nature of the study.
Data collection
Patient data were recorded, including age, gender, body mass index (BMI), smoking history, and alcohol consumption. Heavy drinking was defined as consumption at least twice a week on a single occasion of seven or more drinks (>60 g of alcohol) for men and five or more drinks (>40 g of alcohol) for women. Symptoms of pneumonia, the vital signs, and comorbid conditions were also recorded. The results of the PSI (7), CURB-65 score (8) , and Eastern Cooperative Oncology Group (ECOG) performance status (13) were reviewed. The baseline data were initially recorded by resident physicians and confirmed by attending chest physicians (S.I.C. and C.H.K.). The Charlson comorbidity index (CCI) (14) was calculated retrospectively.
The laboratory results were reviewed, including complete blood counts, erythrocyte sedimentation rates, liver function tests, and levels of CRP, procalcitonin, N-terminal prohormone brain natriuretic peptide (NT-proBNP), troponin I, lactate dehydrogenase (LDH), blood urea nitrogen (BUN), and creatinine. The arterial blood gas analysis data, including the partial pressure of oxygen in the arterial blood (PaO2), the partial pressure of carbon dioxide in the arterial blood (PaCO2), fraction of inspired oxygen (FiO2), and the PaO2/ FiO2 ratio were recorded. The use of mechanical ventilation, corticosteroid, and vasopressor infusion was also noted. Lastly, patients with complicated parapneumonic effusion or empyema and pleural drainage via a percutaneous catheter or chest tube were noted, and these factors were included in the parameters.
Statistical analysis
Statistical analysis was performed using the IBM SPSS Statistics for Windows, version 20.0 software program (IBM, Armonk, USA). Data were expressed as the means ± standard deviation for continuous variables and as numbers along with percentages for categorical variables. Between the two groups, the continuous variables were compared by means of Student's t-test and the Mann-Whitney U test if the distribution was not normal, whereas the categorical variables were compared using a chi-square test or Fisher's exact test. When the continuous variables were converted to categorical variables, the cut-off values were determined using receiver operating characteristic (ROC) curves. A multiple logistic regression analysis was carried out to identify predictors of 30-day mortality. We set up two models that included one of the two clinical tools, that is, the CURB-65 or PSI score. The Hosmer-Lemeshow test was used to determine the goodness-of-fit of the logistic regression models. In addition, we calculated the sensitivities, specificities, positive and negative predictive values, and positive and negative likelihood ratios for predicting adverse outcomes. The MedCalc statistical software program, version 12.0 (MedCalc Software, Ostend, Belgium) was used for the analysis of the ROC curves. p values <0.05 were considered to be statistically significant.
Results
Baseline characteristics
The 797 patients selected for study were divided into two groups based on the 30-day mortality results: those who died [72 (9%)] and those who survived [725 (91%)] groups. The death group was significantly older than the survival 
Laboratory findings
The laboratory results are shown in Table 2 . Of the serum inflammatory markers, the CRP and LDH levels were significantly higher in the death group than in the survival group (18.6±11.0 vs. 13.2±9.7 mg/dL, p<0.001; and 834± 725 vs. 467±295 U/L, p=0.003, respectively), whereas the procalcitonin level was not significantly different between the two groups. The values for NT-proBNP, hemoglobin, albumin, total bilirubin, alkaline phosphatase, blood urea nitrogen (BUN), and the PaO2/FiO2 values all differed significantly between the two groups.
Multivariate analysis for prognostic factors of CAP
According to a univariate analysis to identify the predictors of 30-day mortality, a high CURB-65 score (3-5), high PSI class (V), high ECOG performance status (3-4), dyspnea, pulse rate, CRP, albumin, NT-proBNP, and hemoglobin levels, all of which differed significantly between the two groups (i.e., had p values of <0.001), were selected as potential parameters for the multivariate analysis. Because the PaO2/FiO2 ratio correlated with dyspnea (r=-0.380, p<0.001) and serum total protein correlated with dyspnea and the serum albumin levels (r=0.640, p<0.001), these factors were excluded from the multivariate analysis. A multivariate analysis was performed for the two models to determine which factors were independent predictors of 30-day mortality (Table 3 ). In the CURB-65-based model, these factors were found to be a high CURB-65 score [ The prognostic performance of the single predictors and their combinations are summarized in Table 4 . In this analysis, hypoalbuminemia (<3 g/dL) was substituted for the serum albumin level. In the CURB-65-based model, the CURB-65 score had the highest positive predictive value (32.9%) and positive likelihood ratio (5.0). Among the CURB-65-based two-predictor combinations, the addition of the following three factors, dyspnea, ECOG, and hypoalbuminemia, enhanced the positive predictive values (41.7%, 40.6%, and 42.3%, respectively) and the positive likelihood ratios (7.2, 6.9, and 7.4, respectively). Among the threepredictor combinations, CURB-65/dyspnea/ECOG and CURB-65/dyspnea/hypoalbuminemia increased the positive likelihood ratio to >10. The four-predictor combination had the highest positive predictive value (59.9%) and positive likelihood ratio (15.1). In the PSI-based model, the PSI class had the highest positive predictive value (38.1%) and positive likelihood ratio (6.2). Similar to the CURB-65-based model, the addition of other predictors to the PSI class enhanced the prognostic performance; subsequently, the c-statistic of the PSI class-based four-predictor combination was 0.876.
Discussion
The results of the present study suggest that dyspnea, the ECOG performance status, and serum albumin level might be independent predictors of 30-day mortality in hospitalized CAP patients, along with the CURB-65 score or the PSI. Furthermore, the addition of dyspnea, the ECOG performance status, and hypoalbuminemia to the CURB-65 score or to the PSI improved the prognostic assessment in this group of patients. Three-and four -predictor combinations, which included the CURB-65 score or the PSI, are expected to play a critical role in predicting poor prognoses in patients with CAP. In contrast, we found through a multivariate analysis that biomarkers of inflammation, such as CRP and procalcitonin, were not significant prognostic factors.
Although the CURB-65 score and the PSI have been the most extensively studied models for determining the prognosis in patients with CAP, they still fall short of expectations. The PSI underestimates the risk of a poor prognosis in young adults, whereas the CURB-65 criteria do not adequately evaluate comorbid conditions (6) . The present study also demonstrated that the c-statistics for the CURB-65 and PSI (0.625 and 0.698, respectively) were significant, but not reliable predictors of a poor prognosis in CAP patients. On the multivariate analysis, we identified three predictors of 30-day mortality among these patients with CAP. First, the presence of dyspnea was an independent prognostic factor. This is in accordance with previous studies in which hypoxemia was found to be an independent prognostic factor in patients with pneumonia (15, 16) . In the present study, dyspnea correlated significantly with the PaO2/FiO2 ratio and the respiratory rate (r=-0.380, p<0.001; r=0.345, p<0.001, respectively). Additionally, in a large proportion of these patients, the PaO2/FiO2 data were missing [126/725 (17%) in the survival group], and the respiratory rate (p=0.003 in the univariate analysis) was already included as a parameter in the CURB-65 and PSI assessments. Consequently, these two clinical factors were not included in the multivariate analysis. Although these tools are more objective measures than dyspnea, the latter symptom is easily assessed. In previous studies, dyspnea has been observed more frequently in pneumococcal pneumonia than in pneumonia due to atypical pathogens (17) , in CAP caused by Gram-negative bacilli versus other types of pathogens (18) , and in CAP with asthma versus CAP without asthma (19) . These earlier findings suggested the potential role of dyspnea as a predictor of mortality. Next, the ECOG performance status was a significant predictor of the prognosis, corresponding to previous studies in which the ECOG performance status was shown to be an important predictor of mortality in patients with pneumonia, especially among elderly patients or those with healthcare-associated pneumonia (20) (21) (22) (23) . Although comorbidity and the functional status can be important factors when assessing the severity and prognosis of pneumonia (21, 24) , we found that the use of CCI as a scoring system for comorbidity was not a significant predictor of 30-day mortality, even on the univariate analysis. Finally, the serum albumin level was an independent predictor of the prognosis in the present study. According to previous studies (25, 26) , serum albumin is known to be associated with 28-day mortality in hospitalized patients with CAP, and the albumin level has increased the prognostic performance when combined with the CURB-65 score or the PSI. Albumin is important in maintaining physiological homeostasis and may be decreased during malnutrition and when there is a systemic inflammatory response (27) , which could explain the effect of albumin in predicting mortality in patients with CAP. Serum albumin is an objective variable that is easily measured, inexpensive, and available in most institutions, although it is not always widely used in routine clinical practice (8, 26, 28) . Because the use of either the CURB-65 or PSI alone to predict CAP outcomes has so far been inadequate, there have been a number of efforts to improve the prognostic performance of these tools by adding other prognostic markers to these clinical prediction scores (9, 11, (29) (30) (31) (32) . Our study also showed that using combinations of three-and four-predictors significantly increased the c-statistics to greater than 0.8. Dyspnea, the ECOG performance status, and albumin levels are easily assessed or measured in most institutions upon initial contact with hospitalized patients with CAP, thus three-and four-predictor combinations that include these parameters along with the CURB-65 and PSI results could become a promising prognostic model for predicting CAP outcomes.
Previous studies have demonstrated that the CRP (9, 29), procalcitonin (30, 31) , and NT-proBNP (11, 32) levels could be beneficial in predicting CAP outcomes when used alone or in combination with the clinical prediction scores. However, in our study, the CRP and procalcitonin levels were not significant predictors, although the NT-proBNP level was an independent predictor in the CURB-65-based model.
There are several limitations associated with the present study. First, this was a retrospective study conducted in a single institution, thus selection bias could not be avoided. Because some of the CAP patients were seen in other departments at our institution, all patients with CAP were not screened for enrollment. Additionally, the study was a retrospective analysis of prospectively collected data, thus all decisions regarding treatment, including the selection of antibiotics, were made solely by the treating physicians. Therefore, validation through a prospective study of a large population is needed to confirm the findings of this study. Second, it is possible that missing laboratory data affected our results. Third, because the ECOG performance status was not independently assessed by two clinicians, inter-observer variability could not be analyzed; however, it has been reported that agreement with regard to allocation of the patients to performance status 0-2 vs. 3-4 was high with kappa values of 0.92 and 0.82, respectively (33) . Finally, because the present study included only hospitalized patients with CAP, these same criteria cannot be applied to either outpatients or to the entire CAP population.
In conclusion, three clinical factors, namely dyspnea, the ECOG performance status, and the serum albumin level, rather than certain biomarkers of inflammation, may thus be independent predictors of 30-day mortality in patients with CAP. When combined with the CURB-65 score or PSI, these predictors were helpful for predicting a poor prognosis in CAP patients.
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